Connecticut pharmaceutical giant Pfizer, along with its German partner BioNTech, has been awarded a $1.95 billion dollar contract from the Trump Administration to purchase 100 million doses of a COVID-19 vaccine. “It is encouraging that the data on BNT162b1 from the German study cohort are very much in line with what we have seen in the U.S. study cohort. The preliminary data indicate that our mRNA-based vaccine was able to stimulate antibody as well as T-cell responses at remarkably low dose levels. We believe both may play an important role in achieving effective clearance of a pathogen such as SARS-CoV-2,” said Özlem Türeci, M.D., CMO and Co-founder of BioNTech.
Pfizer won't receive any government funds until a vaccine is produced with F.D.A. approval. If the vaccine, funded by the government works, individual Americans will receive it at no charge.
Comentários